Pre-market Gainers: FormFactor (NASDAQ:FORM), Array Biopharma Inc. (NASDAQ:ARRY), Rockwell Medical Inc. (NASDAQ:RMTI), XenoPort (NASDAQ:XNPT), FuelCell Energy Inc. (NASDAQ:FCEL)

FormFactor Inc. (NASDAQ:FORM) raised its revenue guidance for the second quarter, pointing to strong demand across its system-on-chip and dynamic random access memory segments. FormFactor, Inc. (NASDAQ:FORM) stock opened today at $6.80 and is currently trading at $6.99. The stock showed a positive weekly performance of 9.48%.

Array BioPharma (NASDAQ:ARRY) announced a collaboration agreement with Biogen Idec (NASDAQ: BIIB) for the discovery and development of inhibitors targeting a novel kinase for the treatment of autoimmune disorders. Array Biopharma Inc. (NASDAQ:ARRY) stock opened at $4.39, in current trading session and currently is at $4.25, by gaining 3.66%. The 52 week range of $3.39 – $7.10. Company’s market capitalization is 533.19 million.

Rockwell Medical, Inc. (NASDAQ:RMTI) announced that its New Drug Application (NDA) for Triferic has been accepted for filing by the U.S. Food & Drug Administration (FDA). Triferic is the Company’s iron-replacement drug for treating iron deficiency in chronic kidney disease patients receiving hemodialysis. Rockwell Medical Inc. (NASDAQ:RMTI) stock is currently trading at $11.75. The EPS of the stock is -1.12. Company’s market capitalization is 478.93 million.

XenoPort (NASDAQ:XNPT) Director John Gordon Freund purchased 15,000 shares of the stock on the open market in a transaction dated Friday, May 23rd. The stock was purchased at an average cost of $3.73 per share, with a total value of $55,950.00. Following the acquisition, the director now directly owns 8,899 shares of the company’s stock, valued at approximately $33,193. XenoPort, Inc. (NASDAQ:XNPT) stock opened the session at $4.16, and now is at $4.23. The 52 week range of the XenoPort, Inc. (NASDAQ:XNPT) stock remained $3.14 – $7.20 and the day range was $4.15 – $4.39.

Stifel Nicolaus initiated coverage on shares of FuelCell Energy (NASDAQ:FCEL). Stifel Nicolaus issued a buy rating and a $2.90 price target on the stock. FuelCell Energy Inc. (NASDAQ:FCEL) stock opened today at $2.28 and is currently trading at $2.32. The stock showed a positive weekly performance of 2.29%.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *